Maximilien Evrard

12PUBLICATIONS
122CO-AUTHORS
Tumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Biological adaptationMedical infection agents (incl. prions)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Feb 10, 2026
Flt3L-mediated tumor cDC1 expansion enhances immunotherapy by priming stem-like CD8+ T cells in lymph nodes.

Junyun Lai, Cheok Weng Chan, Jesse D Armitage

|Dec 30, 2025
Antigen reactivity defines tissue-resident memory and exhausted T cells in tumors.

Thomas N Burn, Jan Schröder, Luke C Gandolfo

|Nov 30, 2023
Divergent molecular networks program functionally distinct CD8+ skin-resident memory T cells.

Simone L Park, Susan N Christo, Alexandria C Wells

|Jul 26, 2022
Runx3 drives a CD8+ T cell tissue residency program that is absent in CD4+ T cells.

Raíssa Fonseca, Thomas N Burn, Luke C Gandolfo

|Mar 04, 2022
Transitional premonocytes emerge in the periphery for host defense against bacterial infections.

Ye Chean Teh, Ming Yao Chooi, Dehua Liu

|Oct 22, 2021
Sphingosine 1-phosphate receptor 5 (S1PR5) regulates the peripheral retention of tissue-resident lymphocytes.

Maximilien Evrard, Erica Wynne-Jones, Changwei Peng

Pageof 2